M K Proteins closes trading window ahead of Q2FY27 results declaration

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Trading window closed from October 1, 2026
  • Closure lasts until 48 hours post-Q2FY27 results declaration
  • Applies to all insiders including directors and promoters
  • Filed under SEBI (Prohibition of Insider Trading) Regulations, 2015
powered bylight_fuzz_icon
52138373

*this image is generated using AI for illustrative purposes only.

M K Proteins Limited has closed its trading window for transactions in its shares starting October 1, 2026. The closure remains in effect until the end of 48 hours after the declaration of un-audited financial results for the second quarter and half-year ended September 30, 2026.

This move is pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prohibition of Insider Trading. The restriction applies to employees, directors, key managerial personnel, promoters, designated persons, their immediate relatives, and any other insiders.

Regulatory Compliance Details

The company filed an intimation with both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) on September 28, 2026. The filing confirms that no insider transactions are permitted during this blackout period to prevent potential misuse of unpublished price-sensitive information.

Board Meeting Schedule

The specific date for the Board Meeting to consider the un-audited financial results for Q2FY27 and H1FY27 will be intimated in due course. Until then, the trading window remains strictly closed as per regulatory norms.

Historical Stock Returns for MK Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+2.56%-0.25%-0.74%-8.47%-41.78%+5.26%

How might the upcoming Q2FY27 financial results influence MK Proteins' stock volatility once the trading window reopens?

What are the projected impacts of recent aquaculture feed price fluctuations on MK Proteins' half-year margins?

Will the company announce any strategic capacity expansion plans alongside its Q2 earnings release?

M K Proteins seeks approval for ₹135 crore related party deals at AGM

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • M K Proteins schedules 14th AGM for September 30, 2026, via video conference
  • Seeks approval for ₹135 crore in related-party transactions for FY27
  • Proposes appointment of Ms. Aritika Garg as Independent Director
  • Re-appointment of Sh. Raj Kumar, retiring by rotation, also on agenda
powered bylight_fuzz_icon
49894864

*this image is generated using AI for illustrative purposes only.

M K Proteins has scheduled its 14th Annual General Meeting for September 30, 2026. The meeting will convene at 11:00 am via video conference or other audio-visual means to transact ordinary and special business items.

The board approved the notice and directors report for the fiscal year ended March 31, 2026. Key agenda items include the ratification of cost auditor remuneration, the appointment of an independent director, and omnibus approvals for material related party transactions. The company also dispatched letters to members providing web links to access the Annual Report for FY25-26.

Corporate Action Details

The board meeting commenced at 3:00 pm and concluded at 3:30 pm on September 2, 2026. Directors approved the following items:

  • Notice of the 14th Annual General Meeting
  • Directors Report along with annexures
  • Appointment of Ms. Aritika Garg as Independent Director
  • Ratification of remuneration for Cost Auditors for FY27
  • Approval for material transactions with related parties Kamla Oleo Private Limited and Kamla Oils and Fats Private Limited

The notice of the AGM and the annual report will be dispatched to shareholders and stock exchanges separately in due course. Shareholders without registered email IDs have been sent letters with web links and QR codes to access the documents.

Book Closure Period

Pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the register of members and share transfer books will remain closed.

Event Date
Cut-off Date for E-voting September 23, 2026
Commencement of E-voting September 27, 2026
Conclusion of E-voting September 29, 2026
Book Closure Start September 24, 2026
Book Closure End September 30, 2026
AGM Date September 30, 2026

The closure period includes both start and end dates. Shareholders on record during this window will be eligible to attend the meeting and vote on resolutions. The Board has not recommended any dividend for FY26.

Related Party Transactions

Shareholders are requested to approve omnibus approvals for material related party transactions with two entities for FY27. These approvals are valid until the next AGM in 2027.

Related Party Entity Proposed Transaction Value (₹ crore) Nature of Transaction
Kamla Oleo Private Limited 80 Sale/purchase of goods including Palm Fatty Acid, Non-Edible Oil, Rice Bran Oil and Chemicals
Kamla Oils and Fats Private Limited 55 Sale/purchase of goods including Rice Bran Oil and other Vegetable Oils

The proposed transaction value with Kamla Oleo represents 20.89% of the listed entity's annual consolidated turnover for the preceding financial year. The transaction with Kamla Oils and Fats represents 14.36%. Directors Mr. Parmod Kumar, Mr. Vinod Kumar, Mr. Raj Kumar and Mr. Parvind Kumar have an interest in these transactions by virtue of their directorships or familial relationships with the related parties.

Board Appointments

Ms. Aritika Garg (DIN: 11895058) is recommended for appointment as an Independent Director for a first term of five consecutive years, effective from August 22, 2026. She is a qualified Chartered Accountant with over 15 years of experience in accounting, finance, taxation, and audit.

Additionally, shareholders are asked to re-appoint Sh. Raj Kumar (DIN: 00126983), who retires by rotation at this meeting. He is eligible and has offered himself for re-appointment.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE964W01021/42c16138-0e3b-488c-bd9e-2aac6c73f62a.pdf

Historical Stock Returns for MK Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
+2.56%-0.25%-0.74%-8.47%-41.78%+5.26%

How might the significant volume of related party transactions with Kamla Oleo and Kamla Oils impact M K Proteins' operational independence and profit margins in FY27?

What specific strategic expertise or governance improvements does Ms. Aritika Garg bring to the board that could influence the company's future financial oversight?

Given the board's decision not to recommend a dividend for FY26, what are the company's stated plans for capital allocation or reinvestment in the coming fiscal year?

More News on MK Proteins

1 Year Returns:-41.78%